首页 › 基金 › Versant Venture Management, LLC › IPSC
Versant Venture Management, LLC 对 IPSC 的持仓历史
Century Therapeutics, Inc. · 医疗保健
Versant Venture Management, LLC 在 Q3 2026 的 13F 申报中披露持有 IPSC(Century Therapeutics, Inc.)12,166,109 股,市值约 US$20.8M,约占其申报组合的 19.07%,在其申报持仓中市值排名第 2 位。 Versant Venture Management, LLC 最近 3 个申报季度中有 3 个季度披露了 IPSC 持仓,最早可追溯至 Q1 2026。
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
Versant Venture Management, LLC 对 IPSC 的持仓演变
Versant Venture Management, LLC 于 Q1 2026 首次披露 IPSC 持仓:12,166,109 股(约 US$27.5M)。 该持仓在 Q2 2026 达到峰值 12,166,109 股,市值约 US$29.8M。 在 3 次申报中,Versant Venture Management, LLC 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 12,166,109 股、市值约 US$20.8M。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2026 | 12.17M | $27.50M | 新进 |
| Q2 2026 | 12.17M | $29.81M | 持有 |
| Q3 2026 | 12.17M | $20.80M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 IPSC 与 13F 数据
IPSC(Century Therapeutics, Inc.)属于医疗保健行业。我们追踪的基金中还有 48 只申报持有 IPSC,申报仓位最大的包括:RA CAPITAL MANAGEMENT, L.P. (US$43.5M), TCG Crossover Management, LLC (US$43.4M), Commodore Capital LP (US$21.3M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 IPSC 的基金
- RA CAPITAL MANAGEMENT, L.P. 17.75M 股 · $43.50M · Q2 2026
- TCG Crossover Management, LLC 17.75M 股 · $43.40M · Q2 2026
- Commodore Capital LP 8.70M 股 · $21.30M · Q2 2026
- Venrock Adviser, LLC 8.70M 股 · $21.30M · Q2 2026
- Seven Fleet Capital Management LP 4.35M 股 · $10.65M · Q2 2026
- Trails Edge Capital Partners, LP 4.13M 股 · $10.13M · Q2 2026
- Spruce Street Capital LP 4.06M 股 · $6.94M · Q3 2026
- DAFNA Capital Management LLC 2.40M 股 · $5.88M · Q2 2026
- STEMPOINT CAPITAL LP 2.15M 股 · $5.26M · Q2 2026
- DV Trading LLC 1.40M 股 · $3.43M · Q2 2026
- Casdin 资本 1.23M 股 · $3.01M · Q2 2026
更多关于 Versant Venture Management, LLC
常见问题
How long has Versant Venture Management, LLC held IPSC?
Versant Venture Management, LLC has disclosed IPSC holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Versant Venture Management, LLC's current position in IPSC?
As of Q3 2026, Versant Venture Management, LLC holds 12.17M shares of IPSC (Century Therapeutics, Inc.), valued at $20.80M, representing 19.07% of its reported portfolio and ranking #2.
Has Versant Venture Management, LLC been buying or selling IPSC?
In the latest 13F filing (Q3 2026), Versant Venture Management, LLC held unchanged its position in IPSC. The position peaked in Q2 2026 at 12.17M shares.
Which other funds hold IPSC?
Other major institutional holders of IPSC include RA CAPITAL MANAGEMENT, L.P., TCG Crossover Management, LLC, Commodore Capital LP, among 48 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.